Singapore markets open in 2 hours 2 minutes

Spyre Therapeutics, Inc. (SYRE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
35.19+2.17 (+6.57%)
At close: 04:00PM EDT
35.19 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
886
886
2,329
18,739
0
Operating expenses
Research development
89,504
89,504
58,579
57,069
59,638
Selling general and administrative
39,946
39,946
28,531
27,319
21,843
Total operating expenses
129,450
129,450
87,110
84,388
81,481
Operating income or loss
-128,564
-128,564
-84,781
-65,649
-81,481
Total other income/expenses net
-216,399
-216,399
-7
-122
-5
Income before tax
-338,816
-338,816
-83,951
-65,660
-80,893
Income tax expense
-26
-26
-136
141
0
Income from continuing operations
-338,790
-338,790
-83,815
-65,801
-80,893
Net income
-338,790
-338,790
-83,815
-65,801
-80,893
Net income available to common shareholders
-338,790
-338,790
-83,815
-65,801
-80,893
Basic EPS
-74.15
-49.12
-24.75
-25.00
-38.00
Diluted EPS
-74.15
-49.12
-24.75
-25.00
-38.00
Basic average shares
3,925
6,897
3,371
2,630
2,135
Diluted average shares
3,925
6,897
3,371
2,630
2,135